Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Corcoran

Showing results (201-210 of 278) with videos related to

Pageof 28
Sort By:
The Journal of Clinical Investigation|January 22, 2026
ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription ReprogrammingParasvi S Patel, Jacob P Matson, Xiaojuan Ran, et al.
Cancer Discovery|January 18, 2024
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C CancersDouglas A Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz, et al.
Anaesthesia|April 18, 2023
Machine learning to predict myocardial injury and death after non-cardiac surgeryJ M Nolde, M P Schlaich, D I Sessler, et al.
Lancet (London, England)|October 25, 2019
Anaesthetic depth and complications after major surgery: an international, randomised controlled trialTimothy G Short, Douglas Campbell, Christopher Frampton, et al.
Oncoimmunology|May 4, 2018
A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanomaMeghan J Mooradian, Alexandre Reuben, Peter A Prieto, et al.
JCO Precision Oncology|October 12, 2023
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA TestingStefania Napolitano, Aparna R Parikh, Jason Henry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2019
Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal CancerSophia C Kamran, Jochen K Lennerz, Claire A Margolis, et al.
BJA Open|February 20, 2026
Sugammadex, neostigmine, and postoperative pulmonary complications: protocol of the SNaPP multicentre randomised controlled trialKate Leslie, Sabine Braat, Jai N Darvall, et al.
Cancer Discovery|October 4, 2015
Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric CancerEunice L Kwak, Leanne G Ahronian, Giulia Siravegna, et al.
The Oncologist|October 31, 2018
Enrichment of <i>HER2</i> Amplification in Brain Metastases from Primary Gastrointestinal MalignanciesDevarati Mitra, Jeffrey W Clark, Helen A Shih, et al.
Pageof 28

Showing results (201-210 of 278) with videos related to

Sort By:
Pageof 28
The Journal of Clinical Investigation|January 22, 2026
ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription ReprogrammingParasvi S Patel, Jacob P Matson, Xiaojuan Ran, et al.
Cancer Discovery|January 18, 2024
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C CancersDouglas A Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz, et al.
Anaesthesia|April 18, 2023
Machine learning to predict myocardial injury and death after non-cardiac surgeryJ M Nolde, M P Schlaich, D I Sessler, et al.
Lancet (London, England)|October 25, 2019
Anaesthetic depth and complications after major surgery: an international, randomised controlled trialTimothy G Short, Douglas Campbell, Christopher Frampton, et al.
Oncoimmunology|May 4, 2018
A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanomaMeghan J Mooradian, Alexandre Reuben, Peter A Prieto, et al.
JCO Precision Oncology|October 12, 2023
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA TestingStefania Napolitano, Aparna R Parikh, Jason Henry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2019
Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal CancerSophia C Kamran, Jochen K Lennerz, Claire A Margolis, et al.
BJA Open|February 20, 2026
Sugammadex, neostigmine, and postoperative pulmonary complications: protocol of the SNaPP multicentre randomised controlled trialKate Leslie, Sabine Braat, Jai N Darvall, et al.
Cancer Discovery|October 4, 2015
Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric CancerEunice L Kwak, Leanne G Ahronian, Giulia Siravegna, et al.
The Oncologist|October 31, 2018
Enrichment of <i>HER2</i> Amplification in Brain Metastases from Primary Gastrointestinal MalignanciesDevarati Mitra, Jeffrey W Clark, Helen A Shih, et al.
Pageof 28